Younger adults · Ohio
Studies for younger adults in Ohio
These studies accept adults from 21 or younger and set an upper age limit of 45 or below, so they are aimed at younger adults. Being in the age range does not mean you qualify; screening decides.
46 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 5 other US sites
- Eligibility basics
- Ages 12–30
- RecruitingHealthy volunteersEarly Phase 1
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nationwide Children's Hospital
- Location
- Cincinnati, OH + 1 other US site
- Eligibility basics
- Ages 1–21
- RecruitingHealthy volunteersEarly Phase 1
Impulsivity Domains and Subjective Response
Jessica Weafer
- Location
- Columbus, OH + 1 other US site
- Eligibility basics
- Ages 21–25
- RecruitingHealthy volunteersEarly Phase 1
Effect of C-peptide on Hypoglycemic Counterregulation
University of Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteersPhase 1
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
James Reynolds
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18–35
- RecruitingHealthy volunteersOvernight stay mentioned
Suicide Treatment Alternatives for Teens
Children's Hospital Medical Center, Cincinnati
- Location
- Cincinnati, OH + 2 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteers
Evaluation of Approved Contact Lenses (CR-6657)
Johnson & Johnson Vision Care, Inc.
- Location
- Granville, OH + 3 other US sites
- Eligibility basics
- Ages 18–39
- RecruitingPhase 3
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Cincinnati, OH + 5 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Cincinnati, OH + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 3
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Novo Nordisk A/S
- Location
- Columbus, OH + 26 other US sites
- Eligibility basics
- Ages 8–18
- RecruitingPhase 1
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Solid Biosciences Inc.
- Location
- Columbus, OH + 2 other US sites
- Eligibility basics
- Ages 18–40
- RecruitingPhase 2
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Mirum Pharmaceuticals, Inc.
- Location
- Cincinnati, OH + 13 other US sites
- Eligibility basics
- Ages 13–45 · Men only
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Cincinnati, OH + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Cincinnati, OH + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Columbus, OH + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Cleveland, OH + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 3
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
AstraZeneca
- Location
- Cincinnati, OH + 3 other US sites
- Eligibility basics
- Ages 0 mo–18
- Recruiting
Pro-2-Cool Pivotal Trial II
TecTraum Inc.
- Location
- Akron, OH
- Eligibility basics
- Ages 13–21
- RecruitingPhase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines
- Location
- Cincinnati, OH + 5 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
- Location
- Centerville, OH + 30 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 1/Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Monument Therapeutics Limited
- Location
- Columbus, OH + 14 other US sites
- Eligibility basics
- Ages 17–30
- Recruiting
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
SterileCare Inc.
- Location
- Cincinnati, OH + 6 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Amgen
- Location
- Cleveland, OH + 4 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Cincinnati, OH + 34 other US sites
- Eligibility basics
- Ages 12–18